Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Знаете ли вы? Кликните два раза на слово, чтобы найти его в TermGallery.
Значения термина biologic agents на английском
Значения для термина "biologic agents" отсутствуют.
Использование термина biologic agents на английском
1
Recent and ongoing trials of novel chemotherapeutic and biologicagents are reviewed.
2
A range of novel biologicagents, different from the conventional therapies, became available.
3
Other biologicagents are likely to be added to this list in the future.
4
In 1996, experience in treating autoimmune rheumatic diseases with biologicagents has further improved.
5
Various biologicagents have been attempted for HS, but there is still no definitive treatment.
6
Little is known about the association between disease duration and response to other biologicagents.
7
Given its good toxicity profile, capecitabine was assessed in combination with several chemotherapeutic or biologicagents.
8
This study was conducted to indirectly compare the efficacy of biologicagents for treatment of active AS.
9
Given the short duration of response more focus should be given to newer biologicagents and triplet regimens.
10
Also, downregulation of Bcl-2 protein can result in reversal of chemotherapy resistance and improved antitumor activity of biologicagents.
11
These biologicagents have proven useful for treating many inflammatory illnesses, as well as providing insight into disease pathogenesis.
12
Methods: A narrative literature review of studies investigating the use of biologicagents for the management of osteoarthritis was conducted.
13
This article reviews the current state-of-the-art therapy with regards to the use of biologicagents as treatments for systemic vasculitis.
14
A delayed response or slowed growth may be characteristic of biologicagents being evaluated in the treatment of malignant glioma.
15
Before TCZ was commenced, ME was present, and all patients had been previously treated with immunosuppressive therapy and biologicagents.
16
Background: The development of biologicagents directed against distinct cytokines and receptors has advanced the therapeutic options available for psoriasis patients.